Skip to main content

Table 3 Data of patients with stage IB2 and IIA2 cervical cancer before and after matching

From: Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals

VariablesUnmatchedMatched
R-CT (n = 261)RH (n = 553)p-valueR-CT (n = 235)RH (n = 235)p-value
Age (years)51.2 ± 10.447.6 ± 8.70.00050.4 ± 8.850.3 ± 8.70.924
FIGO stage  0.000  1.000
 IB260 (23.0%)322 (58.2%) 56 (23.8%)56 (23.8%) 
 IIA2201 (77.0%)231 (41.8%) 179 (76.2%)179 (76.2%) 
Histological type  0.000  1.000
 SCC241 (92.3%)513 (92.8%) 228 (97.0%)228 (97.0%) 
 AC11 (4.2%)31 (5.6%) 3 (1.3%)3 (1.3%) 
 SAC9 (3.5%)9 (1.6%) 4 (1.7%)4 (1.7%) 
Tumour size  0.000  1.000
  > 4 cm230 (88.1%)434 (78.5%) 210 (89.4%)210 (89.4%) 
  ≤ 4 cm31 (11.9%)119 (21.5) 25 (10.6%)25 (10.6%) 
  1. R-CT radio-chemotherapy, RH radical hysterectomy with postoperative standard therapy, FIGO International Federation of Gynecology and Obstetrics, SCC squamous cell carcinoma, AC adenocarcinoma, SAC adenosquamous carcinoma